Phase III Clinical Study of Intravenous Administration of S-021812 in Pediatric Patients with Influenza Virus Infectio
Phase 3
- Conditions
- Influenza virus infection
- Registration Number
- JPRN-jRCT2080220845
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Pediatric patient diagnosed as influenza virus infection
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, Safety
- Secondary Outcome Measures
Name Time Method